413 related articles for article (PubMed ID: 9536081)
1. Truncated N-terminal fragments of huntingtin with expanded glutamine repeats form nuclear and cytoplasmic aggregates in cell culture.
Cooper JK; Schilling G; Peters MF; Herring WJ; Sharp AH; Kaminsky Z; Masone J; Khan FA; Delanoy M; Borchelt DR; Dawson VL; Dawson TM; Ross CA
Hum Mol Genet; 1998 May; 7(5):783-90. PubMed ID: 9536081
[TBL] [Abstract][Full Text] [Related]
2. Aggregation of N-terminal huntingtin is dependent on the length of its glutamine repeats.
Li SH; Li XJ
Hum Mol Genet; 1998 May; 7(5):777-82. PubMed ID: 9536080
[TBL] [Abstract][Full Text] [Related]
3. Rapid aggregate formation of the huntingtin N-terminal fragment carrying an expanded polyglutamine tract.
Hazeki N; Nakamura K; Goto J; Kanazawa I
Biochem Biophys Res Commun; 1999 Mar; 256(2):361-6. PubMed ID: 10079189
[TBL] [Abstract][Full Text] [Related]
4. A cellular model that recapitulates major pathogenic steps of Huntington's disease.
Lunkes A; Mandel JL
Hum Mol Genet; 1998 Sep; 7(9):1355-61. PubMed ID: 9700187
[TBL] [Abstract][Full Text] [Related]
5. Tissue transglutaminase selectively modifies proteins associated with truncated mutant huntingtin in intact cells.
Chun W; Lesort M; Tucholski J; Faber PW; MacDonald ME; Ross CA; Johnson GV
Neurobiol Dis; 2001 Jun; 8(3):391-404. PubMed ID: 11442349
[TBL] [Abstract][Full Text] [Related]
6. Polyglutamine pathogenesis.
Ross CA; Wood JD; Schilling G; Peters MF; Nucifora FC; Cooper JK; Sharp AH; Margolis RL; Borchelt DR
Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1005-11. PubMed ID: 10434299
[TBL] [Abstract][Full Text] [Related]
7. In vitro evidence for both the nucleus and cytoplasm as subcellular sites of pathogenesis in Huntington's disease.
Hackam AS; Singaraja R; Zhang T; Gan L; Hayden MR
Hum Mol Genet; 1999 Jan; 8(1):25-33. PubMed ID: 9887328
[TBL] [Abstract][Full Text] [Related]
8. Altered proteasomal function due to the expression of polyglutamine-expanded truncated N-terminal huntingtin induces apoptosis by caspase activation through mitochondrial cytochrome c release.
Jana NR; Zemskov EA; Wang Gh ; Nukina N
Hum Mol Genet; 2001 May; 10(10):1049-59. PubMed ID: 11331615
[TBL] [Abstract][Full Text] [Related]
9. Nuclear targeting of mutant Huntingtin increases toxicity.
Peters MF; Nucifora FC; Kushi J; Seaman HC; Cooper JK; Herring WJ; Dawson VL; Dawson TM; Ross CA
Mol Cell Neurosci; 1999 Aug; 14(2):121-8. PubMed ID: 10479410
[TBL] [Abstract][Full Text] [Related]
10. Mutant huntingtin forms in vivo complexes with distinct context-dependent conformations of the polyglutamine segment.
Persichetti F; Trettel F; Huang CC; Fraefel C; Timmers HT; Gusella JF; MacDonald ME
Neurobiol Dis; 1999 Oct; 6(5):364-75. PubMed ID: 10527804
[TBL] [Abstract][Full Text] [Related]
11. Wild type Huntingtin reduces the cellular toxicity of mutant Huntingtin in mammalian cell models of Huntington's disease.
Ho LW; Brown R; Maxwell M; Wyttenbach A; Rubinsztein DC
J Med Genet; 2001 Jul; 38(7):450-2. PubMed ID: 11432963
[TBL] [Abstract][Full Text] [Related]
12. Huntingtin fragments that aggregate go their separate ways.
DiFiglia M
Mol Cell; 2002 Aug; 10(2):224-5. PubMed ID: 12191468
[TBL] [Abstract][Full Text] [Related]
13. Polyglutamine repeat length-dependent proteolysis of huntingtin.
Sun B; Fan W; Balciunas A; Cooper JK; Bitan G; Steavenson S; Denis PE; Young Y; Adler B; Daugherty L; Manoukian R; Elliott G; Shen W; Talvenheimo J; Teplow DB; Haniu M; Haldankar R; Wypych J; Ross CA; Citron M; Richards WG
Neurobiol Dis; 2002 Oct; 11(1):111-22. PubMed ID: 12460551
[TBL] [Abstract][Full Text] [Related]
14. Tissue transglutaminase does not contribute to the formation of mutant huntingtin aggregates.
Chun W; Lesort M; Tucholski J; Ross CA; Johnson GV
J Cell Biol; 2001 Apr; 153(1):25-34. PubMed ID: 11285271
[TBL] [Abstract][Full Text] [Related]
15. Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin.
Schilling G; Becher MW; Sharp AH; Jinnah HA; Duan K; Kotzuk JA; Slunt HH; Ratovitski T; Cooper JK; Jenkins NA; Copeland NG; Price DL; Ross CA; Borchelt DR
Hum Mol Genet; 1999 Mar; 8(3):397-407. PubMed ID: 9949199
[TBL] [Abstract][Full Text] [Related]
16. Long glutamine tracts cause nuclear localization of a novel form of huntingtin in medium spiny striatal neurons in HdhQ92 and HdhQ111 knock-in mice.
Wheeler VC; White JK; Gutekunst CA; Vrbanac V; Weaver M; Li XJ; Li SH; Yi H; Vonsattel JP; Gusella JF; Hersch S; Auerbach W; Joyner AL; MacDonald ME
Hum Mol Genet; 2000 Mar; 9(4):503-13. PubMed ID: 10699173
[TBL] [Abstract][Full Text] [Related]
17. Complex interplay between the length and composition of the huntingtin-derived peptides modulates the intracellular behavior of the N-terminal fragments of mutant huntingtin.
Milewski M; Gawliński P; Bąk D; Matysiak A; Bal J
Eur J Cell Biol; 2015 May; 94(5):179-89. PubMed ID: 25773959
[TBL] [Abstract][Full Text] [Related]
18. Dopamine D1 receptor-mediated aggregation of N-terminal fragments of mutant huntingtin and cell death in a neuroblastoma cell line.
Robinson P; Lebel M; Cyr M
Neuroscience; 2008 May; 153(3):762-72. PubMed ID: 18403126
[TBL] [Abstract][Full Text] [Related]
19. Huntington's disease intranuclear inclusions contain truncated, ubiquitinated huntingtin protein.
Sieradzan KA; Mechan AO; Jones L; Wanker EE; Nukina N; Mann DM
Exp Neurol; 1999 Mar; 156(1):92-9. PubMed ID: 10192780
[TBL] [Abstract][Full Text] [Related]
20. DMSO and glycerol reduce bacterial death induced by expression of truncated N-terminal huntingtin with expanded polyglutamine tracts.
Nagao Y; Ishiguro H; Nukina N
Biochim Biophys Acta; 2000 Oct; 1502(2):247-56. PubMed ID: 11040449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]